Literature DB >> 1269198

The effect of arterial oxygen tension on antipyrine half-time in plasma.

J F Cumming.   

Abstract

Hospital patients with depressed arterial oxygen tensions (PaO2) from pulmonary disease were given antipyrine orally or intravenously. The half-time (t1/2) of disappearance from plasma was measured. Other patients with normal PaO2 measurements were treated similarly. Patients whose PaO2 was 55 or below had longer t1/2 times than those of patients with a PaO2 above 55. This observation parallels that made previously in rats.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269198

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

Review 1.  Drugs and brain death.

Authors:  M Kennedy; N Kiloh
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

Review 2.  The metabolic function of the lung.

Authors:  W J Wijnands
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

Review 3.  Pulmonary disease and drug kinetics.

Authors:  P du Souich; A J McLean; D Lalka; S Erill; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

4.  Antipyrine elimination in critically ill patients.

Authors:  L Mirvis; N Buchanan; C Eyberg
Journal:  Intensive Care Med       Date:  1979-05       Impact factor: 17.440

5.  Chronic pulmonary disease and antipyrine disposition.

Authors:  S N Agnihotri; R A Clark; S Cooper; A O Iyun; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

6.  Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure.

Authors:  P du Souich; S Erill
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

Review 7.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 8.  Hypoxia, arterial pH and theophylline disposition.

Authors:  M Richer; Y W Lam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

9.  Alfentanil infusions on the intensive therapy unit.

Authors:  M E Sinclair; J W Sear; R J Summerfield; A Fisher
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

10.  Intermittent Hypoxia Inhibits Hepatic CYP1a2 Expression and Delays Aminophylline Metabolism.

Authors:  Xiao-Bin Zhang; Xiao-Yang Chen; Kam Yu Chiu; Xiu-Zhen He; Jian-Ming Wang; Hui-Qing Zeng; Yiming Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-29       Impact factor: 2.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.